Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT01206647

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as a collaborator
Registry
  • NCT NCT01206647
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01206647. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Metformin and Saxagliptin
Lead sponsor
ikfe-CRO GmbH (class: industry)
Collaborator
AstraZeneca (class: industry)
Collaborator
IKFE Institute for Clinical Research and Development (class: other)

Record details

Record id
cardio:ct-nct01206647
Content hash
9681dba6c2ca75f761f2eb59bf4e7e585abeb87228768b0317328bcce1ff6cbd